Company Filing History:
Years Active: 2017-2019
Title: Sushil Raina: Innovator in Kynurenine Pathway Research
Introduction
Sushil Raina is a notable inventor based in Noida, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors targeting the kynurenine pathway. With a total of 2 patents, his work is paving the way for new therapeutic approaches.
Latest Patents
Raina's latest patents focus on novel inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2, and tryptophan 2,3-dioxygenase. These compounds, along with their metabolites and pharmaceutically acceptable salts or prodrugs, are designed to treat diseases resulting from dysregulation of the kynurenine pathway. The compounds act by inhibiting the enzymatic activity or expression of the aforementioned enzymes, showcasing their potential in therapeutic applications.
Career Highlights
Throughout his career, Sushil Raina has worked with reputable organizations, including Curadev Pharma Pvt Ltd and Curadev Pharma Private Limited. His experience in these companies has allowed him to collaborate with other experts in the field and contribute to innovative research.
Collaborations
Some of his notable coworkers include Monali Banerjee and Sandip Middya. Their collaborative efforts have further advanced the research and development of inhibitors in the kynurenine pathway.
Conclusion
Sushil Raina's work in developing inhibitors for the kynurenine pathway represents a significant advancement in biochemistry and therapeutic research. His contributions are essential for the ongoing exploration of treatments for diseases linked to this pathway.